Blockchain Registration Transaction Record

Hoth Therapeutics Partners with Lantern Pharma on AI Drug Platform

Hoth Therapeutics partners with Lantern Pharma to use AI platform PredictBBB.ai for drug development. Technology predicts blood-brain barrier penetration with 94% accuracy.

This collaboration represents a significant advancement in neurological drug development that could accelerate treatments for conditions like Alzheimer's, Parkinson's, and brain cancers. The blood-brain barrier has been one of the most challenging obstacles in developing effective CNS medications, causing many promising drugs to fail in late-stage development. By using AI to accurately predict which compounds can cross this barrier, pharmaceutical companies can save years of research time and millions in development costs, potentially bringing life-changing neurological treatments to patients much faster. This technology addresses a fundamental bottleneck that has limited progress in treating brain disorders for decades.